Fidelity Advisor Europe Fund - Class C (FHJTX)
| Fund Assets | 933.15M |
| Expense Ratio | 1.81% |
| Min. Investment | $0.00 |
| Turnover | 51.00% |
| Dividend (ttm) | 0.56 |
| Dividend Yield | 1.21% |
| Dividend Growth | 3.01% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 29, 2025 |
| Previous Close | 47.06 |
| YTD Return | 1.51% |
| 1-Year Return | 19.48% |
| 5-Year Return | 21.70% |
| 52-Week Low | 39.98 |
| 52-Week High | 49.35 |
| Beta (5Y) | n/a |
| Holdings | 101 |
| Inception Date | Mar 18, 2014 |
About FHJTX
Fidelity Advisor Europe Fund – Class C is a mutual fund designed to provide long-term capital growth by focusing primarily on securities of European issuers. The fund typically invests at least 80% of its assets in European companies, covering a broad spectrum of sectors including healthcare, technology, consumer cyclical, energy, and basic materials. Its portfolio features prominent holdings such as Novo Nordisk, ASML Holding, AstraZeneca, and LVMH Moet Hennessy Louis Vuitton, reflecting significant exposure to large-cap, growth-oriented companies across the European continent. The fund employs a growth investment style and is categorized within the Europe Stock peer group, making it a vehicle for investors seeking diversified access to developed European markets within an actively managed structure. It maintains a moderate annual turnover rate and is subject to a net expense ratio consistent with Class C shares. Since its inception in 2014, the Fidelity Advisor Europe Fund – Class C has played a role in offering tailored exposure to European equities, catering to individuals and institutions aiming to diversify their global holdings and capitalize on the economic and corporate developments across Europe.
Performance
FHJTX had a total return of 19.48% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.83%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
Top 10 Holdings
32.33% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 5.40% |
| AstraZeneca PLC | AZN | 3.95% |
| Roche Holding AG | ROP | 3.78% |
| Siemens Energy AG | ENR | 3.48% |
| Shell plc | SHEL | 3.27% |
| Rolls-Royce Holdings plc | RR | 3.06% |
| Fidelity Cash Central Fund | n/a | 2.67% |
| Taiwan Semiconductor Manufacturing Company Limited | TSM | 2.33% |
| Banco Santander, S.A. | SAN | 2.31% |
| UCB SA | UCB | 2.10% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 29, 2025 | $0.124 | Dec 30, 2025 |
| Dec 12, 2025 | $0.561 | Dec 15, 2025 |
| Dec 13, 2024 | $0.665 | Dec 16, 2024 |
| Dec 8, 2023 | $0.077 | Dec 11, 2023 |
| Dec 3, 2021 | $5.641 | Dec 6, 2021 |
| Dec 4, 2020 | $0.062 | Dec 7, 2020 |